RegenLab France SAS
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Combination of PRP and XLHA Prepared With RegenMatrix Medical Device To Treat Moderate to Severe Knee Osteoarthritis (NCT05727371) | RegenLab France SAS | 2023-08-21 |
Track RegenLab France SAS automatically
Every clearance here is in the API, with alerts when new ones post.